BioWorld by Clarivate Celebrates 35 Years of Trusted Biopharma and Medtech Journalism
Award-winning independent news and analysis continue to guide life sciences leaders through rapid scientific and market change
London, U.K. — September 18, 2025 — BioWorld, published by Clarivate Plc (NYSE:CLVT), today announced its 35th anniversary, recognizing 35 years as a leading digital-first source of trusted coverage across the global biopharmaceutical and medical technology industries. With an archive of more than 380,000 articles and 77 journalism awards, BioWorld has become the definitive news service for executives, investors and policymakers navigating discovery, development and commercialization.
In an era of digital disruption and rapid biopharma and medtech innovation, the media industry has experienced significant upheaval, including consolidation and the rise of misinformation. Amid these pressures, BioWorld stands apart as a trusted, data-informed source of timely, contextualized journalism, delivering clarity and authority across biopharma and medtech. BioWorld reporting is regularly cited by regulators, investors and industry leaders, underscoring its role as a daily reference point for critical decisions.
Lynn Yoffee, Publisher, BioWorld, said: “BioWorld’s 35th anniversary is not just a celebration of longevity, it is a testament to the enduring value of trusted, independent journalism in the life sciences. The BioWorld mission has always been to cut through the noise with accuracy, clarity and context. As we look ahead, we will continue to expand our global coverage and integrate deeper insights from Clarivate data, ensuring BioWorld remains an indispensable resource for the industry’s next generation of leaders.”
Bradley Burnam, CEO, Turn Therapeutics, added: “BioWorld is one of the most respected and widely read publications in the biotech and pharmaceutical world. Its readers include executives at major pharma companies, top-tier investors, leading scientists and policymakers. Being featured by BioWorld means our work is recognized as meaningful and credible by some of the most influential voices in the industry.”
David Schull, President, Russo Partners LLC, noted: “BioWorld stands head and shoulders above other life sciences media outlets with its sharp focus on in-depth, accurate and comprehensive reporting. When we work with BioWorld staffers, we know the commitment is to get the facts right, no matter the news. Balanced. Fair. BioWorld remains true to its mission and is the go-to source for daily industry information.”
Launched as a print magazine in 1990 before quickly moving to fax and online distribution in 1991, BioWorld was among the first digital-first news services in the life sciences industry. Expanding in 1994 with BioWorld MedTech, it broadened coverage to medical devices and technologies, cementing its role as a trusted authority in healthcare reporting. In 2018, BioWorld further deepened its discovery and preclinical coverage with the launch of BioWorld Science, previously Prous Science Daily Essentials. Since 1998, BioWorld has earned 77 awards, including seven recent honors from Apex — among them a Grand Award for a special series on pioneering efforts to develop a universal HIV cure — recognizing excellence in journalism, analysis and digital publishing.
As BioWorld marks 35 years, it is not only reflecting on its legacy but also investing in the future, expanding coverage, leveraging Clarivate’s data-driven insights, and reaffirming its commitment to editorial independence. This positions BioWorld to remain the essential daily read for life sciences leaders navigating discovery, development and commercialization for decades to come.
Discover how BioWorld helps industry leaders cut through the noise, here.
Join the conversation and mention BioWorld on X and LinkedIn and Clarivate for Life Sciences & Healthcare on X and LinkedIn.
About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com
Media Contact:Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
